Cover of New Yorker article on "The Birth Tissue Profiteers". Illustration by Ben Jones When you have a great story to tell the best and most effective way to get it out to the widest audience is still the media, both traditional mainstream and new social media. Recently we have seen three great examples of … Continue reading Media matters in spreading the word
Stem cell tourism
Mending Stem Cells: The Past, Present & Future of Regenerative Medicine
UCSF's Mission Bay Campus For years we have talked about the “promise” and the “potential” of stem cells to cure patients. But more and more we are seeing firsthand how stem cells can change a patient’s life, even saving it in some cases. That’s the theme of the 4th Annual CIRM Alpha Stem Cell Clinics … Continue reading Mending Stem Cells: The Past, Present & Future of Regenerative Medicine
Targeting clinics offering bogus stem cell therapies
For some years now CIRM has been raising the alarm about the growing numbers of clinics offering unproven and unapproved stem cell therapies. But we are not alone. Now a leader of the California state Assembly is taking action, trying to ensure the clinics follow the law and don’t endanger patients. Kevin Mullin is the … Continue reading Targeting clinics offering bogus stem cell therapies
Peddling hope for thousands of dollars – a TV expose on one clinic offering unproven stem cell therapies
You may have seen an ad in your local paper, promoting a seminar on the “wonders” of stem cell therapies. They are becoming increasingly common all around the US. The ads talk about the ability of stem cells to heal everything from arthritis to autism. But what they don’t talk about is that they are … Continue reading Peddling hope for thousands of dollars – a TV expose on one clinic offering unproven stem cell therapies
Research Targeting Prostate Cancer Gets Almost $4 Million Support from CIRM
A program hoping to supercharge a patient’s own immune system cells to attack and kill a treatment resistant form of prostate cancer was today awarded $3.99 million by the governing Board of the California Institute for Regenerative Medicine (CIRM) In the U.S., prostate cancer is the second most common cause of cancer deaths in men. … Continue reading Research Targeting Prostate Cancer Gets Almost $4 Million Support from CIRM
Stem Cell Roundup: Jake Javier’s amazing spirit; TV report highlights clinic offering unproven stem cell therapies
In the Roundup we usually focus on studies that highlight advances in stem cell research but today we’re going to do something a little different. Instead of relying on print for our stories, we’re turning to video. We begin with a piece about Jake Javier. Regular readers of our blog will remember that Jake is … Continue reading Stem Cell Roundup: Jake Javier’s amazing spirit; TV report highlights clinic offering unproven stem cell therapies
Using the courts to protect patients from unapproved stem cell therapies
A recent article in Nature looked at using lawsuits to help rein in the activities of clinics offering "unapproved" therapies. CIRM's Geoff Lomax explains. When public health officials wanted to raise awareness about the dangers of smoking they filed lawsuits against the tobacco companies. They accused Big Tobacco of deceptive marketing and hiding the negative … Continue reading Using the courts to protect patients from unapproved stem cell therapies
Stem Cell Stories that Caught Our Eye: New law to protect consumers; using skin to monitor blood sugar; and a win for the good guys
New law targets stem cell clinics that offer therapies not approved by the FDA For some time now CIRM and others around California have been warning consumers about the risks involved in going to clinics that offer stem cell therapies that have not been tested in a clinical trial or approved by the U.S. Food … Continue reading Stem Cell Stories that Caught Our Eye: New law to protect consumers; using skin to monitor blood sugar; and a win for the good guys
‘Pay-to-Participate’ stem cell clinical studies, the ugly stepchild of ClinicalTrials.gov
When patients are looking for clinical trials testing new drugs or treatments for their disease, one of the main websites they visit is ClinicalTrials.gov. It’s a registry provided by the National Institutes of Health (NIH) of approximately 250,000 clinical trials spanning over 200 countries around the world. If you visit the website, you’ll find CIRM’s … Continue reading ‘Pay-to-Participate’ stem cell clinical studies, the ugly stepchild of ClinicalTrials.gov
Texas tries to go it alone in offering unproven stem cell therapies to patients
One of the most hotly debated topics in stem cell research is whether patients should be able to have easier access to unproven therapies using their own stem cells, at their own risk, and their own cost. It’s a debate that is dividing patients and physicians, researchers and lawmakers. In California, a bill working its … Continue reading Texas tries to go it alone in offering unproven stem cell therapies to patients